Dash Bio reported raising $30 Million in an initial SEC Form D filing, from an offering of $30 Million
Round Type
Series A
BostonBiotechnologyInvestors
Description
Dash Bio has raised $30 million in Series A financing to enhance infrastructure for next-generation medicine development. The round was led by Oak HC/FT, with participation from existing investors Freestyle Capital and Swift Ventures. This funding aims to streamline drug development processes that are often resource-intensive. Dash Bio is focused on modernizing the support infrastructure for drug development.
Who to call at Dash Bio, and when
A new round usually means Dash Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Dash Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Dash Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Dash Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Dash Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansDash Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.